The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3-(9-(Cyclopropanecarbonyl)-3,9-diazaspiro[5.5]undecane-3-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one ID: ALA4174140
PubChem CID: 145950405
Max Phase: Preclinical
Molecular Formula: C29H31FN4O3
Molecular Weight: 502.59
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCC2(CC1)CCN(C(=O)C1CC1)CC2
Standard InChI: InChI=1S/C29H31FN4O3/c30-24-8-5-19(18-25-21-3-1-2-4-22(21)26(35)32-31-25)17-23(24)28(37)34-15-11-29(12-16-34)9-13-33(14-10-29)27(36)20-6-7-20/h1-5,8,17,20H,6-7,9-16,18H2,(H,32,35)
Standard InChI Key: WNSCHUNLCBKWPT-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 42 0 0 0 0 0 0 0 0999 V2000
22.5842 -20.9498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5801 -21.7670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2818 -22.1769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9922 -21.7741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.9963 -20.9569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2901 -20.5425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5252 -17.6851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5241 -18.5047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2321 -18.9136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2303 -17.2763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9389 -17.6815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9378 -18.5022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6440 -18.9112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3559 -18.5042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3570 -17.6835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6463 -17.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6463 -16.4528 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6417 -19.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3483 -20.1390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3446 -20.9550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0504 -21.3655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7602 -20.9588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7598 -20.1374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0535 -19.7306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4673 -21.3685 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.4673 -19.7283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1753 -20.1364 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4667 -18.9111 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1711 -20.9504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8750 -21.3584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5862 -20.1346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8777 -19.7221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6972 -22.1873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6920 -23.0044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4076 -21.7832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2244 -21.7843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8204 -21.0739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
9 12 2 0
11 10 2 0
10 7 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 2 0
13 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
23 26 1 0
26 27 1 0
26 28 2 0
27 29 1 0
27 32 1 0
29 30 1 0
30 1 1 0
1 31 1 0
31 32 1 0
4 33 1 0
33 34 2 0
33 35 1 0
36 35 1 0
37 36 1 0
35 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 502.59Molecular Weight (Monoisotopic): 502.2380AlogP: 3.91#Rotatable Bonds: 4Polar Surface Area: 86.37Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.96CX Basic pKa: ┄CX LogP: 2.80CX LogD: 2.80Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.59Np Likeness Score: -1.34
References 1. Reilly SW, Puentes LN, Wilson K, Hsieh CJ, Weng CC, Makvandi M, Mach RH.. (2018) Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity., 61 (12): [PMID:29856625 ] [10.1021/acs.jmedchem.8b00576 ]